Oxford researchers investigating hydroxychloroquine and chloroquine for prevention of COVID-19

The University of Oxford and Oxford Tropical Medicine Research Unit are leading on a double-blind, randomised, placebo-controlled study (COPCOV) aiming to enrol 40,000 healthcare staff to determine if hydroxychloroquine and chloroquine can prevent COVID-19.

Source:

PharmaTimes